Pramila Jayapal addresses health care cuts, tariffs, and NYC shooting victim

U.S. Rep. Pramila Jayapal representing Washington%27s 7th Congressional District - Official U.S. House headshot
U.S. Rep. Pramila Jayapal representing Washington's 7th Congressional District - Official U.S. House headshot
0Comments

U.S. Representative Pramila Jayapal, who represents Washington’s 7th district in Congress, addressed several issues on her Twitter account on July 30, 2025, including health care policy, the impact of tariffs on prescription drug prices, and the recent shooting death of Aland Etienne in New York City.

In a post made at 01:09 UTC, Jayapal wrote, “We are going to make sure every single Republican who voted to strip away our health care is held accountable. It’s time to stand up and fight back to cancel these cuts.”

Later that day at 14:12 UTC, she commented on the potential effects of former President Donald Trump’s trade policies: “Trump’s tariffs will make your prescription drugs more expensive.”

At 16:10 UTC, Jayapal expressed condolences following a fatal shooting in New York City involving a union member. She stated, “My heart goes out to the friends and family of Aland Etienne, a victim of the shooting in NYC and a dedicated @SEIU member. He worked everyday to keep his city safe and will be remembered as a hero.”

Jayapal has represented Washington’s 7th District in Congress since 2017 after succeeding Jim McDermott. Prior to her tenure in Congress, she served in the Washington State Senate from 2014 to 2016. Born in Chennai in 1965 and currently residing in Seattle, Jayapal graduated from Georgetown University with a BA in 1986 and earned an additional degree from Northwestern University in 1990.



Related

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA

FDA inspects InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle on July 21, 2024

On July 21, 2024, InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle underwent an FDA inspection focused on food and cosmetics technical assistance, according to information available on the FDA’s website.

Mark Raza Principal Deputy Chief Counsel - FDA

Mark N. Fluchel, M.D. in Seattle scheduled for FDA inspection on Nov. 21, 2024

Mark N. Fluchel, M.D., based in Seattle, underwent an FDA bioresearch monitoring inspection on November 21, 2024, according to information available on the FDA’s website.

James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer

Kalsada Coffee Company in Seattle inspected by FDA on July 1, 2024

The Food and Drug Administration conducted an inspection of Kalsada Coffee Company in Seattle on July 1, 2024, focusing on foodborne biological hazards, according to FDA website data.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.